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Abstract
Background: Despite its potential benefits over univariate, chemometrics is rarely utilized for optimizing sequential
injection analysis (SIA) methods. Specifically, in previous vis-spectrophotometric SIA methods, chemometrically
optimized conditions were confined within flow rate and reagent concentrations while other conditions were
ignored.
Results: The current manuscript reports, for the first time, a comprehensive screening of conditions controlling vis-
spectrophotometric SIA. A new diclofenac assay method was adopted. The method was based on oxidizing
diclofenac by permanganate (a major reagent) with sulfuric acid (a minor reagent). The reaction produced a
spectrophotometrically detectable diclofenac form. The 26 full-factorial design was utilized to study the effect of
volumes of reagents and sample, in addition to flow rate and concentrations of reagents. The main effects and all
interaction order effects on method performance, i.e. namely sensitivity, rapidity and reagent consumption, were
determined. The method was validated and applied to pharmaceutical formulations (tablets, injection and gel).
Conclusions: Despite 64 experiments those conducted in the current study were cumbersome, the results
obtained would reduce effort and time when developing similar SIA methods in the future. It is recommended to
critically optimize effective and interacting conditions using other such optimization tools as fractional-factorial
design, response surface and simplex, rather than full-factorial design that used at an initial optimization stage. In
vis-spectrophotometric SIA methods those involve developing reactions with two reagents (major and minor),
conditions affecting method performance are in the following order: sample volume > flow rate ≈ major reagent
concentration >> major reagent volume ≈ minor reagent concentration >> minor reagent volume.
Background
Sequential injection analysis (SIA) is the second genera-
tion of an extended family called flow injection (FI)
techniques [1]. SIA gathers valuable advantages, includ-
ing automation, miniaturization, versatility and cost-
effectiveness, over other generations and versions of FI
techniques. Recent articles reviewing the principles,
developments and applications of FI techniques are
available elsewhere [2,3].
On the other hand, optimizing experimental condi-
tions is a prior in developing analytical methods. A lit-
erature survey was carried out by the Scopus® database
using the phrase “sequential injection analysis”. Since
the introduction of SIA technique in 1990 [1], the sur-
vey has enumerated 639 articles. Within the extracted
results, a further literature survey, using the keywords
“chemometrics” or “multivariate”, was carried out. In
the latter survey, thirty-nine articles were found, i.e. the
rest of articles reported developing SIA methods using
the univariate approach.
The univariate approach optimizes conditions one-by-
one by varying levels of one condition while levels of
other conditions are held at constant levels. This proce-
dure makes the univariate approach time- and reagent-
consuming. Moreover, the univariate approach is unable
to consider interaction effect between conditions and
hence the maximum efficiency of analytical methods
might not be obtained.
On the other hand, chemometrices, as a group of mul-
tivariate approaches, is more powerful than the univariate
approach. The strategy of chemometrics is that to obtain
the highest efficiency of analytical methods in the short-
est way. Hence, chemometrices reduces consumption of
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reagents and sample, besides it saves time and minimizes
effort. Chemometrics gains its strategy throughout the
following ways: (i) examining the effect of conditions and
their interactions on the efficiency of analytical methods,
(ii) optimizing conditions with considering their interac-
tions, (iii) developing more than one analytical aspect
at the same time, (iv) reducing a large amount of
data that can be easily interpreted and (v) testing the
ruggedness [4-6].
Among the most common effective chemometric opti-
mization approaches are the experimental design-based
methods. The remarkable applications of experimental
design include factor screening, response surface exami-
nation, system optimization and system robustness. Fac-
torial design, which is the dominant factor screening
method, allows to select which factors are significant
and at what levels [4-6].
On the other side, for its selectivity, simplicity and
familiarity, spectrophotometric detection is frequently
used with SIA [7-10]. In SIA with UV detection, multi-
variate curve resolution with alternating least squares
(MCR-ALS), as a chemometric tool, was successfully
utilized to treat second-order data in order to optimize
resolution using UV detection [11-15]. However, the
most applied spectrophotometric detection that used
with SIA methods is in the vis range, which is more
selective. In those methods, chromogenic reactions,
which most probably are redox, complexation, ion pair-
ing and charge transfer, are usually applied. Most of
those reactions involved two reagents or more [16-26].
In those methods, the chemometrically optimized condi-
tions limited within flow rate and concentrations of
reagents while other such effective conditions as
volumes of reagents and sample were neglected.
Therefore, it has been proposed, for the first time, to
screen conditions controlling vis-spectrophotometric
SIA methodologies. An issue that would reduce effort
and time when developing new methods in the future.
As an example, a new vis-spectrophotometric SIA
method for the assay of diclofenac was adopted.
Diclofenac is chemically named 2-[(2,6-dichlorophe-
nyl)aminophenyl]-acetic acid (Figure 1). It is a potent
analgesic and anti-inflammatory agent. Due to its use
for many treatments, diclofenac is prepared in a wide
range of formulations including tablets, capsules, drops,
injections, suppositories, gels and ointments. The exten-
sive worldwide use of diclofenac has aroused researchers
to develop many assay methods using various analytical
techniques. In this issue, it has been found that, within
the last five years, more than fifteen methods were
reported. Gravimetry [27], spectrophotometry [28,29],
fluorometry [30], Raman Spectroscopy [31,32], diffuse
reflectance photometry [33], potentiometry [34,35], mul-
tisyringe flow injection analysis with amperometry [36],
liquid chromatography [37,38], high performance liquid
chromatography [39-41], thin layer chromatography
[42], high performance thin chromatography [43] and




Recently, permanganate, as the superior oxidizing agent
with its high absorptivity, has been found selective in
controlled conditions for the assay of some medicines in
their formulations [17,19,26,45,46]. In the current work,
it has been found that diclofenac can be oxidized by
permanganate in sulphuric acid media. The oxidized
form of diclofenac is spectrophotometrically detectable
at 450 nm.
Before undertaking any screening study, it is impor-
tant to delineate clearly the boundaries of conditions
controlling SIA. The minimum and maximum applied
levels of conditions are introduced in Table 1.
Regarding levels of flow rate for spectrophoto-
metric measurement, following the practice of SIA
[17-19,21,23,24,26,45,46], 15-30 μL/s is the most
suitable range. Flow rate lower than 15 μL/s decreases
sample frequency while flow rate higher than 30 μL/s
decreases repeatability.
The range of 1.0 - 5.0 mmol/L was adopted for per-
manganate concentration. Higher diclofenac concentra-
tion might not be completely oxidized by permanganate
concentration lower than the adopted range. On the






Figure 1 Chemical structure of sodium diclofenac.
Table 1 Levels of experimental condition applied for the
26 full-factorial design optimization
Experimental condition Minimum level Maximum level







Permanganate volume (μL) 50 100
Sulphuric acid volume (μL) 30 60
Diclofenac volume (μL) 30 60
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adopted range, significant absorbance of diclofenac was
not obtained.
For sulfuric acid concentration, a level higher than
100 mmol/L distorted the base line of a SIA-gram and
produced poor repeatability as in previous procedures
[17-19,21,23,24,26,45,46]. On the contrary, acid concen-
trations bellow 10 mmol/L did not record significant
absorbance.
The volume ranges of reagents and sample were
adopted based upon the criteria of that to obtain signifi-
cant absorbance and acceptable repeatability. It has been
found that, generally, high volume produced non-repea-
table results while low volumes decreased absorbance.
Screening of conditions using factorial design
Unless otherwise described the term “response” refers
here to the absorbance of an oxidized form of diclofe-
nac. As mentioned before, the 26 full-factorial design
was adopted. The base 2 stands for the minimum and
the maximum levels of experimental conditions. The
power 6 is the number of experimental conditions those
would be optimized, which include flow rate, permanga-
nate concentration, sulfuric acid concentration, perman-
ganate volume, sulfuric acid volume and sample
volume. A total of 64 experiments using 100 μg/mL
diclofenac, as the result of the 26 full-factorial design,
were conducted. For validation purpose, each experi-
ment was repeated three times, which is practicable
when using such a fully-automated technique as SIA.
It was found that the experiment that included the
conditions of low flow rate (15 μL/s), high permanga-
nate concentration (5.0 mmol/L), high acid concentra-
tion (100 mmol/L), low permanganate volume (50 μL),
high acid volume (60 μL) and high sample volume
(60 μL) recorded the highest response, which was 1.87.
Another experiment also recorded almost the same
response, namely 1.77. The conditions of the latter
experiment are the same of the frontal experiment with
the exception of the use of low acid volume (30 μL).
The main effects “E”, n = 6, and all interaction order
effects, n = 57, on absorbance were calculated using
equation 1 [4-6]. “y(+1)” and “y(-1)” are the absorbance
values at the minimum and the maximum levels of an
examined factor, respectively. “n” is the number of
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A wide range of grades, ranging from 0.005 to 0.450, was
obtained. To simplify that range, effect factors > 0.1 were
considered significant. It has been found that for effect fac-
tor of < 0.1 the difference in responses at minimum and
maximum levels of a condition, e.g. acid volume, with
other fixed conditions was almost less than 0.1. From the
viewpoint of spectrophotometry, the difference in absor-
bance of < 0.1 is insignificant. Figure 2 shows factors of
> 0.1, which is considered, as relatively effective factors. It
has been found that the most effective factor is sample
volume that positively effect on response. High diclofenac
volume increases the number of moles of diclofenac and
hence increases absorbance. In the second order of effect
is the positive effect of permanganate concentration and
negative effect of flow rate (Figure 2). Negative effect of
the latter condition indicates slow oxidation reaction of
diclofenac. Increasing permanganate concentration with
increasing response emphasizes that the oxidation of
diclofenac by acidified permanganate is slow. Regarding
other main factors, permanganate volume and acid con-
centration recorded relatively lower effect than other main
factors while acid volume did not record significant effect.
On the other side, although the effect of both permanga-
nate concentration and flow rate are in the same order,
the most significant interaction effect was recorded for
sample volume with permanganate concentration.
In order to set up the optimum conditions, it has to
compromise between results obtained from factorial
design and those obtained from the calculation of
effect factors. Primarily, there was no significant differ-
ence between the responses obtained from experiments
those recorded the responses of 1.87 and 1.77, which
differed in acid volume. The results obtained from the
calculations of the main and interaction effect factors
show that acid volume has the lowest effect (Figure 2).
Therefore, the maximum efficiency, in terms of sensi-
tivity, rapidity and reagent consumption, of the pro-
posed SIA method can be extracted from conditions of
experiment that recorded the response of 1.77. Conse-
quently, the optimum adopted conditions were mini-
mum flow rate (15 μL/s), maximum permanganate
concentration (5.0 mmol/L), minimum acid concentra-
tion (10 mmol/L), minimum permanganate volume
(50 μL), minimum acid volume (30 μL) and maximum
diclofenac volume (60 μL).
Method validation
To examine the linear range and the weighed regression
of calibration equation, a long series of diclofenac stan-
dard solutions were applied to the proposed SIA proce-
dure under the optimum conditions. The method was
found to be linear, with a correlation coefficient of
0.9998, in the range of 10 - 150 μg/mL. The weighed
regression of calibration is described in equation 2. “A”
is the absorbance of the oxidized form of diclofenac. “C”
is the concentration of diclofenac. Figure 3 shows a
SIA-gram obtained by a one-shot run of four standard
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Figure 2 Most effective main and interacting conditions on the response of the SIA method. FR: flow rate (μL/s), MnOV: permanganate
volume (μL), DicV: diclofenac volume (μL), AV: acid volume (μL), AC: acid concentration (mmol/L), MnOC: permanganate concentration (mmol/L).
Figure 3 Spectrophotometric SIA-gram of four diclofenac standard solutions (10, 50, 100 and 150 μg/mL). Each solution was measured
four times.
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solutions (10, 50, 100 and 150 μg/mL) of diclofenac;
each standard solution was measured four times.
A C= +0 003 0 024. . (2)
To examine the repeatability and the intermediate-pre-
cision, a standard solution of 50 μg/mL diclofenac was
applied to the SIA method seven times in a day and five
times over a week, respectively. The relative standard
deviation (RSD) for repeatability study was 1.34% while
the RSD for inter-mediate precision was 2.75%. The auto-
mation of SIA rendered the proposed method precise.
The limits of detection (LOD) and quantification (LOQ)
were also examined. LOD was obtained as the concentra-
tion of a solute resulting in a peak height three times the
baseline noise level. LOQ was obtained as the concentra-
tion of solute resulting in a peak height ten times the base-
line noise level. The LOD and LOQ were found to be 1.37
and 4.57 μg/mL, respectively. Satisfactorily detectability of
the SIA method was obtained by successful optimization.
Method application
The method was applied to bulk and pharmaceutical sam-
ples, namely tablets, injection and gel. Bulk, tablets and
injection samples were also applied to the British Pharma-
copoeia (BP) methods [47]. The BP recommends a classical
potentiometric method for diclofenac assay in raw materi-
als while a LC method is recommended for tablet and gel
formulations [47]. For diclofenac assay in injection formu-
lation, a previous validated HPLC method was applied [48].
Each sample was analyzed seven times. The recovery, RSD
and t-test values were calculated. The obtained results are
introduced in Table 2. The experimental t-test values were
lower than those tabulated values, which prove the reliabil-
ity of the current SIA method.
Experimental
Instrumentation
The assembly constructed for the current work included
a SIA system, miniaturized fiber optic spectrometric
devices and pumped-tubes (Figure 4).
The SIA system is a FIALab® 3500 (Medina, WA
USA). It is composed of a syringe pump (SP), multi-
position valve (MPV), holding coil (HC), Z-flow cell
(Z), pump tubing and personal computer (PC). The SP
includes 24,000 increments with high-resolution step-
per motor, which drives the piston at rates from
1.5 seconds to 10.0 min per stroke with > 99% accu-
racy at full stroke. The syringe has a volume of 2.5
mL. The MPV is chemically inert and has eight ports
with a standard pressure of 250 psi (gas)/600 psi
(liquid); zero dead volume. The Z is a 10 mm path-
length Plexiglass compatible with fiber optic connec-
tors. Pump tubing was used to connect sequential
injection analyzer devices and to make HC with a long
of 200 cm. Pumped tubes of “0.03 inch” ID Teflon
type was supplied from Upchurch Scientific, Inc. (Oak
Harbor, WA, USA).
The optical manifold included a radiation source, spec-
trometer and fiber optic connectors. All optical devices
were fabricated by Ocean Optics (Dunedin Florida,
USA). The radiation source is an LS-1 Tungsten Halogen
Lamb optimized for VIS-NIR (360 nm - 2 μm wavelength
range). The detector is a USB2000 Spectrometer adapted
to 200 - 1100 nm wavelength range. The fiber optic con-
nectors are 200 micron Sub-Miniature version A®.
FIALab® for Windows version 5.0 supplied from FIA-
lab (Medina, WA, USA) was used for programming and
controlling the whole assembly.
Chemicals and reagents
All chemicals and reagents, which were used in this
study, were of analytical reagent grade. The quality of
water was distilled deionized. Diclofenac sodium was
supplied from Sigma (Taufkirchen, Germany). Potassium
permanganate and sulphuric acid were supplied from
Fluka (Buchs, Switzerland). Diclofenac sodium in the
bulk form as well as inactive ingredients those possibly
found in pharmaceutical formulations were a generous
gift from Samf® Medicinal Factory (Khartoum North,
Sudan). Inactive ingredients included sodium citrate,
microcrystalline cellulose, magnesium stearate, maize
starch, carnauba wax, povidone and talc.
Pharmaceutical samples
Olefn™-25 tablets (25 mg diclofenac sodium),
Olefn™-50 tablets (50 mg diclofenac sodium), Olefn®-
75 I.M. (75 mg diclofenac sodium) ampoules, which
were prepared by Mepha Ltd. Aesch-Basel, Switzer-
land, were examined in the current study. Voltaren®
gel (1% (w/w) diclofenac sodium), which was prepared
by Novartis, Aesch-Basel, Switzerland, was also exam-
ined. Diclogesic® gel (1% (w/w) diclofenac sodium)
that was prepared by Dar Al-Dawa, Naur, Jordan was
examined as well.
Table 2 Results obtained by the SIA method and realized
by the British Pharmacopoeia method for diclofenac
assay in raw materials and pharmaceutical formulations





Samf® Bulk - 99.3 ± 1.45 2.14
OlfenTM-25 Tablets 25 mg 98.5 ± 2.14 2.06
OlfenTM-50 Tablets 50 mg 98.1 ± 2.81 2.11
Olfen®-75 I.M. Injection 75 mg
in 2 ml
99.1 ± 2.26 1.87
Voltaren® Gel 1% (w/w) 103.4 ± 3.49 2.23
Diclogesic® Gel 1% (w/w) 102.7 ± 3.18 2.70
1: RSD: relative standard deviation for 7 replicates; 2: t-test value.
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Preparation of reagents and standard solutions
A standard stock solution of 20 mmol/L potassium per-
manganate was prepared and standardized weekly in an
appropriate way. An appropriate amount of diclofenac
was dissolved in water to prepare 1000 μg/mL as stock
standard solution. Working standard solutions of diclo-
fenac, potassium permanganate and sulfuric were daily
prepared by dilution.
Preparation of pharmaceutical samples
Twenty tablets were triturated and homogenized. An
appropriate quantity, which is equivalent to 50 μg/mL
diclofenac, was weighed and dissolved in 10 mL of
water. Then, the obtained solution was heated in water-
bath at 85°C for 5 min and centrifuged for 5 min. The
supernatant was filtered directly into a volumetric flask
with an appropriate volume. The remaining material in
the tube was treated two times again with hot water
according to a previous procedure [47]. Finally, after
cooling at room temperature, water was added to the
solution to complete the volume of the volumetric flask.
For injection preparation, ten ampoules were dis-
charged and mixed. An adequate volume was diluted to
obtain 50 μg/mL diclofenac.
For gel preparation, five tubes were released. An accu-
rately weighed portion of gel was treated as the tablet
preparation procedure [47].
Sequential injection analysis procedure
As shown in Figure 4, a single-channel SIA manifold
was constructed to perform on-line developing reaction
and spectrophotometric measurement. The Z was
attached to port-1 in the MPV. The radiation source
and the spectrometer were connected with the Z by
fiber optic connecters. Water, as a propelling solution,
was linked with the in-position mode. Sulphuric acid,
permanganate and placebo solutions were linked with
port-2 to 4, respectively, in the MPV. Four standard/
sample solutions were attached to port-5 to -8. As
briefly described below, a rapid protocol controlling the
proposed SIA procedure was programmed.
i. Following the practice of SIA, each solution was
loaded into their relative tubes by aspiration using
the SP. Then, excess volumes were dispensed to the
waste.
ii. To propel solutions, the syringe was filled with
1500 μL of water.
iii. For blank measurement, acid and permanganate
solutions were sequentially aspirated into the HC.
iv. The solutions were mixed using three times
reverse-flow of 10 μL volume at a flow rate of
10 μL/s.
v. A placebo solution was injected into the HC and
mixed with acidified permanganate as in step iv.
vi. The mixture was dispensed through Z at the
required flow rate. The peak height (PA) of absor-
bance was recorded.
vii. For standard/sample measurement, steps iv-vi
were repeated with replacing a standard/sample
solutions instead of a placebo solution.
Conclusions
The current work deals with the screening of conditions




























Figure 4 Schematic diagram of a SIA manifold constructed for diclofenac assay in pharmaceutical formulations.
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new assay method for diclofenac. From the obtained
results, the following conclusions can be made.
i. Full-factorial design is a powerful tool for the
screening of conditions controlling SIA. It is also
powerful for optimizing conditions at initial stage.
However, other such chemometric approaches as
fractional-factorial design, response surface and sim-
plex could be more powerful for further optimiza-
tion stages.
ii. In developing vis-spectrophotometric SIA meth-
ods those involve a developing reaction with two
reagents (major and minor), it has been found that
the main factors with their effect types, i.e. positive
or negative, were ordered as follows: (+ sample
volume) > (- flow rate) ≈ (+ major reagent concen-
tration) >> (+ major reagent volume) ≈ (- minor
reagent concentration) >> (+ minor reagent volume).
iii. It has been also found that there was a significant
interaction effect between sample volume and major
reagent concentration.
iv. Generally, in SIA that involves a developing reac-
tion, it is recommended to utilize a chemometric tool
for optimizing effective conditions (i.e. sample volume,
flow rate and major reagent concentration) while less
effective conditions could be fixed at suitable levels.
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